Procore signs multi-year strategic collaboration agreement with AWS
In a challenging market environment, Bovie Medical Corp (NASDAQ:APYX) stock has reached a 52-week low, dipping to $0.84. According to InvestingPro data, the company maintains a healthy current ratio of 5.26, indicating strong short-term liquidity despite recent market pressures. This latest price level reflects a significant downturn for the company over the past year, with the stock experiencing a 1-year change of -37.33%. The company’s financial health score from InvestingPro is rated as "FAIR," with analysis showing the stock is currently undervalued. Investors are closely monitoring APYX as it navigates through the pressures that have led to this decline, seeking signs of potential recovery or further indicators of market headwinds that could impact the stock’s performance. With revenue of $48.1M in the last twelve months and a gross profit margin of 61.04%, the company shows some fundamental strengths despite operating challenges. Discover more insights and 6 additional ProTips with an InvestingPro subscription, including detailed analysis in the comprehensive Pro Research Report.
In other recent news, Apyx Medical (TASE:BLWV) reported its fourth-quarter earnings for 2024, which exceeded analyst expectations. The company posted an earnings per share (EPS) of -$0.12, outperforming the forecasted -$0.16. Revenue for the quarter reached $14.2 million, surpassing the anticipated $13.02 million. Apyx Medical’s Advanced Energy (NASDAQ:AEIS) segment maintained stable revenue year-over-year, while the OEM division saw a 16% decline. Despite these mixed results, the company experienced a 5% increase in global handpiece shipments, with a notable 20% growth in the U.S. market. Analysts from Citizens JMP maintained a Market Perform rating on Apyx Medical following these results. Additionally, Apyx Medical has submitted its Ayon body contouring system for FDA approval, ahead of schedule, with plans for a launch in the second half of 2025. The company also anticipates workforce reductions and cost-saving measures to lower operating expenses in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.